Serum TARC/CCL17 levels are increased in dermatomyositis associated with interstitial lung disease.
Kawashima
Tomohiko
T
Tada
Yayoi
Y
Asano
Yoshihide
Y
Yazawa
Norihito
N
Tomita
Manabu
M
Tamaki
Zenshiro
Z
Kubo
Masahide
M
Ihn
Hironobu
H
Sugaya
Makoto
M
Kadono
Takafumi
T
Tamaki
Kunihiko
K
Sato
Shinichi
S
D000328:Adult; D000368:Aged; D054414:Chemokine CCL17 / Q000097:blood*; D016572:Cyclosporine / Q000627:therapeutic use; D003882:Dermatomyositis / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D017563:Lung Diseases, Interstitial / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D018396:Mucin-1 / Q000097:blood; D011239:Prednisolone / Q000627:therapeutic use; D037663:Pulmonary Surfactant-Associated Protein D / Q000097:blood; D015854:Up-Regulation
C106230:CCL17 protein, human; D054414:Chemokine CCL17; C060192:MUC1 protein, human; D018396:Mucin-1; D037663:Pulmonary Surfactant-Associated Protein D; D016572:Cyclosporine; D011239:Prednisolone; D007770:L-Lactate Dehydrogenase